Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Cash Flow 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow | 828.0M | 572.8M | 159.3M | 175.9M | 304.5M | 85.4M | 48.3M | 20.2M | -8.8M | -227.8M | -59.6M | 17.6M | 18.4M | 18.7M | 87.7M | -9.2M |
| Depreciation & Amort. | 79.6M | 96.4M | 104.4M | 102.0M | 108.0M | 105.2M | 105.3M | 95.7M | 87.9M | 96.9M | 36.0M | 44.3M | 35.0M | 27.7M | 21.0M | 17.6M |
| Investing Activities | ||||||||||||||||
| Capital Expenditure | 103.0M | 85.4M | 96.7M | 121.0M | 95.6M | 114.3M | 145.0M | 144.6M | 199.2M | 148.4M | 65.2M | 44.6M | 73.2M | 49.5M | 89.8M | 56.4M |
| Free Cash Flow | 725.0M | 487.4M | 62.6M | 54.9M | 209.0M | -28.9M | -96.8M | -124.4M | -208.0M | -376.2M | -124.8M | -27.0M | -54.8M | -30.7M | -2.1M | -65.5M |
| Financing Activities | ||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | 0 | 0 | 50.0M | 0 | 0 | — | — | — | — | — | — | — | — |
Biomarin Pharmaceutical Inc. Cash Flow — FAQ
Biomarin Pharmaceutical Inc. (BMRN) cash flow over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's cash flow history?
The chart and table above show Biomarin Pharmaceutical Inc.'s cash flow by year and by quarter, including the growth rate.